Literature DB >> 12707194

Endoscopic laser-assisted excision of juvenile nasopharyngeal angiofibromas.

Eric A Mair1, Andrew Battiata, John D Casler.   

Abstract

BACKGROUND: Juvenile nasopharyngeal angiofibromas (JNAs) are highly vascular tumors that originate in the nasopharynx of young males. The primary treatment is surgical excision. Traditional surgical approaches are associated with significant morbidity and facial deformity. We introduce and outline the clinical advantages of an endoscopic surgical approach to JNAs using the Nd:YAG laser with image-guided surgery.
DESIGN: Case series.
SETTING: Tertiary care medical center. PATIENTS AND METHODS: Our study included 5 male patients (age range, 8-21 years) with extensive JNAs. Their tumors were large and ranged from Fisch stage IIA to IIIA. Embolization of tumor-feeding vessels was performed before surgery. The tumors were photocoagulated via a transnasal endoscopic approach using a Nd:YAG laser. Devascularized, lased tumor was removed with a microdebrider. Image-guided navigation systems were used to assist skull base tumor removal, and sublabial and buccolabial incisions were used as needed to gain lateral endoscopic tumor access. Endoscopic tumor margins were obtained for frozen section.
RESULTS: All patients achieved symptomatic remission, with no complications. No blood transfusions were necessary. The patients were ready for discharge 1 to 2 days after surgery. Postoperative and magnetic resonance imaging scans showed 2 skull base recurrences, which were removed endoscopically. Follow-up ranged between 2 and 3 years.
CONCLUSIONS: Traditional external surgical approaches to large JNAs may result in significant morbidity. Laser-assisted image-guided endoscopic excision of JNAs is a safe and effective minimally invasive surgical treatment. Its distinct advantages include (1) diminished blood loss, (2) superior cosmesis without observed altered facial growth, (3) direct access of skull base with minimal morbidity, and (4) ease of endoscopic follow-up.

Entities:  

Mesh:

Year:  2003        PMID: 12707194     DOI: 10.1001/archotol.129.4.454

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  Endoscopic Approach to Fisch Stage II to III-b Juvenile Nasopharyngeal Angiofibroma.

Authors:  Brajendra Baser; Shenal Kothari; Arvind Kinger
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-13

Review 2.  Inverted papillomas and benign nonneoplastic lesions of the nasal cavity.

Authors:  John W Wood; Roy R Casiano
Journal:  Am J Rhinol Allergy       Date:  2012 Mar-Apr       Impact factor: 2.467

3.  Juvenile Nasopharyngeal Angiofibroma: A Case Report.

Authors:  Soubhagini Acharya; Choubarga Naik; Siddharth Panditray; Subha Soumya Dany
Journal:  J Clin Diagn Res       Date:  2017-04-01

4.  A giant juvenile nasopharyngeal angiofibroma.

Authors:  Salim Yüce; Ismail Önder Uysal; Mansur Doğan; Kerem Polat; Ismail Salk; Suphi Müderris
Journal:  J Craniofac Surg       Date:  2013-05       Impact factor: 1.046

5.  Juvenile nasopharyngeal angiofibroma: current treatment modalities and future considerations.

Authors:  John M Hodges; A S McDevitt; A I El-Sayed Ali; M E Sebelik
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-10-12

6.  Juvenile angiofibroma: evolution of management.

Authors:  Piero Nicolai; Alberto Schreiber; Andrea Bolzoni Villaret
Journal:  Int J Pediatr       Date:  2011-11-17

7.  An effective technique for endoscopic resection of advanced stage angiofibroma.

Authors:  Mojtaba Mohammadi Ardehali; Seyyed Hadi Samimi; Mehdi Bakhshaee
Journal:  Iran J Otorhinolaryngol       Date:  2014-01

8.  Nasopharyngeal angiofibroma: Our experience and literature review.

Authors:  Mariane Barreto Brandão Martins; Francis Vinicius Fontes de Lima; Carlos Alberto Mendonça; Eduardo Passos Fiel de Jesus; Arlete Cristina Granizo Santos; Valéria Maria Prado Barreto; Ronaldo Carvalho Santos
Journal:  Int Arch Otorhinolaryngol       Date:  2013-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.